FcGPT: Generative AI to design the antibody region that controls immune response, for safer and more effective therapeutics

Research unit

INNOSUISSE

Project number

139.749 INNO-LS

Project title

FcGPT: Generative AI to design the antibody region that controls immune response, for safer and more effective therapeutics

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Biotechnology and processing
Abstract (English)	Fy Cappa Biologics develops an AI platform to create novel antibody Fc regions, the part of an antibody that determines its lifetime, biological activity, and safety. Unlike conventional approaches, the platform generates entirely new designs, expanding opportunities for next-generation medicines.